Increasing interest has been focused on myocardial contrast echocardiograph
y (MCE) since latest imaging technologies allow the detection of echocontra
st agents within myocardial structures following intravenous injections. Al
though numerous studies on different aspects of pre-clinical and clinical a
pplications have been published, MCE has not yet become a standard clinical
application. This paper summarises and estimates the clinical value of the
recent developments in this evolving field of research, particularly with
regard to the new real-time perfusion imaging technologies.